Sama Therapeutics

Sama Therapeutics is a leading biotechnology research company specializing in AI-powered precision neuropsychiatry. Located at 1 Leighton St #1904, Cambridge, MA 02141, US, Sama Therapeutics is dedicated to synthesizing and validating predictive biomarkers using neural, physiological, multi-omics, natural language, and behavioral phenotypes.

The company's innovative iMAGiNE™ SaaS platform analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI. By leveraging both proprietary and open-science datasets, Sama Therapeutics is at the forefront of advancing software as a medical device for various indications, including cognitive, affective, interoceptive, and substance use disorders.

With an interdisciplinary team and a commitment to unlocking brain health, Sama Therapeutics invites partners to join its mission through integrative neurotechnology and proven transprognostic algorithms. Sama Therapeutics continues to push the boundaries of biotechnology research and precision medicine. Sama Therapeutics also has offices in Paris, FR, Austin, Texas, US, Chicago, Illinois, US and Nijmegen, NL.

To the manager of Sama Therapeutics, we invite you to create a customized and exclusive company showcase and product listing on our platform.